Matrix assisted cell transplantation of brown fat
Matrix assisted cell transplantation of brown fat
批准号:
9304213
负责人:
KEVIN Edward HEALY
金额:
$41.95万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-06 至 2019-06-30
关键词:
AdhesionsAdipose tissueAdrenergic AgentsAdultAffectAnimalsAutologousAutologous TransplantationBasal metabolic rateBiological AssayBiologyBiomedical EngineeringBody TemperatureBody Weight decreasedBrown FatCaloriesCategoriesCell CountCell RespirationCell SeparationCell TransplantationCell TransplantsCellsCharacteristicsCollaborationsDataDevelopmentDiabetes MellitusDietDiseaseEnergy MetabolismEngineeringFatty AcidsFatty LiverGenerationsGenetic ModelsGlucoseGoalsGrowth FactorHormonesHyaluronic AcidHydrogelsImplantIn VitroInjectableInjection of therapeutic agentLeadLigandsLipoproteinsLiver diseasesLocationMaintenanceMesenchymal Stem CellsMetabolicMetabolic ControlMetabolismMethodsMitochondriaModulusNon-Insulin-Dependent Diabetes MellitusObesityPathway interactionsPerformancePharmacologic SubstancePharmacologyPhenotypeProcessRespirationRestRiskRunningSerumSignal TransductionSiteSourceSystemTestingThermogenesisTissue DifferentiationTissue EngineeringTissue ExpansionTissue-Specific Gene ExpressionTissuesTransgenesTranslatingWeightWorkadipokinesbasecellular transductioncombatdesignexperimental studyfallsfood consumptiongene therapyglucose toleranceimplantationin vivoinsulin sensitivityinsulin toleranceinterdisciplinary approachinterestmetabolic ratenovelnovel strategiesobesity treatmentpre-clinicalpublic health relevanceuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Brown adipose tissue (BAT) possesses the inherent ability to dissipate metabolic energy as heat in a process termed non-shivering thermogenesis and thus could lend itself to novel anti-obesity treatment approaches. Strategies for expanding BAT fall into two general categories, pharmaceutical/genetic intervention to trigger endogenous BAT differentiation pathways or ex vivo generation/expansion of brown fat followed by implantation. Since pharmacological activation of differentiation pathways that might drive a white adipose tissue (WAT) to BAT transition, or "browning" of WAT, runs the risks of affecting differentiation and function of other tissues and offers poor control of the location and extend of
BAT expansion, we will focus on the latter approach. Our overall strategy in this collaboration between the Stahl and Healy labs will be to leverage expertise in bioengineering of hydrogels and in metabolic biology to demonstrate the feasibility of a BAT base anti-obesity strategy that could be readily translated from the pre-clinical stage to actual application. The central hypothesis here is that a multidisciplinary approach of metabolic biology and tissue engineering can be utilized to develop an autologous transplantation approach to expand BAT mass and resting energy expenditure to combat obesity-associated disorders such as type-2 diabetes and hepatosteatosis. Our approach will focus on: 1) utilizing WAT as a readily available source of mesenchymal stem cells (MSC) and to optimize BAT differentiation conditions, without the introduction of transgenes, by combining soluble signaling factors with optimized adhesion ligands; 2) development of 3D matrixes composed of bio-inspired hyaluronic acid (HyA) hydrogels that can be designed to enhance the differentiation of WAT-derived MSCs into BAT; 3) to perform in vivo experiments with matrixes that have been tested ex vivo to further optimize for in vivo performance with a specific focus on determining tissue persistence, maintenance of BAT phenotype, cellular energetics, and whole animal metabolism as a function of matrix composition, growth factors, and implantation site; and 4) to demonstrate that optimized BAT-MACTs can indeed be used as a potent anti-obesity approach and facilitate the protection and reversal of obesity associated disorders.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jconrel.2015.04.034
发表时间:
2015-07-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
[Jha AK, Mathur A, Svedlund FL, Ye J, Yeghiazarians Y, Healy KE]
通讯作者:
Healy KE
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
-
批准号:10216389
-
项目类别:
-
资助金额:$230.55万
-
财政年份:2018
-
负责人:KEVIN Edward HEALY
-
依托单位:
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
-
批准号:10462610
-
项目类别:
-
资助金额:$228.78万
-
财政年份:2018
-
负责人:KEVIN Edward HEALY
-
依托单位:
Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus
-
批准号:10224184
-
项目类别:
-
资助金额:$229.45万
-
财政年份:2018
-
负责人:KEVIN Edward HEALY
-
依托单位:
Human heart-on-a-chip for screening cardiomyopathy and chemotherapeutic cardiotoxicity
-
批准号:9240184
-
项目类别:
-
资助金额:$59.23万
-
财政年份:2017
-
负责人:KEVIN Edward HEALY
-
依托单位:
iPSC Derived Cardiac Microchambers for Embryonic Drug Screening
-
批准号:9068913
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2015
-
负责人:KEVIN Edward HEALY
-
依托单位:
iPSC Derived Cardiac Microchambers for Embryonic Drug Screening
-
批准号:8953685
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2015
-
负责人:KEVIN Edward HEALY
-
依托单位:
Matrix assisted cell transplantation of brown fat
-
批准号:8776672
-
项目类别:
-
资助金额:$41.82万
-
财政年份:2014
-
负责人:KEVIN Edward HEALY
-
依托单位:
Multivalent Conjugates for Enhanced Bioactivity of Growth Factor Based Therapies
-
批准号:8544176
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Disease-Specific Integrated Microphysiological Human Tissue Models
-
批准号:8768902
-
项目类别:
-
资助金额:$82.99万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Multivalent Conjugates for Enhanced Bioactivity of Growth Factor Based Therapies
-
批准号:8431289
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Disease-Specific Integrated Microphysiological Human Tissue Models
-
批准号:8516128
-
项目类别:
-
资助金额:$77.15万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Disease-Specific Integrated Microphysiological Human Tissue Models
-
批准号:8668704
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Disease-Specific Integrated Microphysiological Human Tissue Models
-
批准号:8415488
-
项目类别:
-
资助金额:$89.36万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Disease-Specific Integrated Microphysiological Human Tissue Models
-
批准号:9117652
-
项目类别:
-
资助金额:$80.59万
-
财政年份:2012
-
负责人:KEVIN Edward HEALY
-
依托单位:
Stem Cell Engineering Training Program
-
批准号:8291229
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2011
-
负责人:KEVIN Edward HEALY
-
依托单位:
Stem Cell Engineering Training Program
-
批准号:8508958
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2011
-
负责人:KEVIN Edward HEALY
-
依托单位:
Stem Cell Engineering Training Program
-
批准号:8152036
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2011
-
负责人:KEVIN Edward HEALY
-
依托单位:
Stem Cell Engineering Training Program
-
批准号:8895985
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2011
-
负责人:KEVIN Edward HEALY
-
依托单位:
Nanopatterned Surfaces to Control Cell Fate
-
批准号:8000255
-
项目类别:
-
资助金额:$10.53万
-
财政年份:2010
-
负责人:KEVIN Edward HEALY
-
依托单位:
Nanopatterned Surfaces to Control Cell Fate
-
批准号:8058790
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2009
-
负责人:KEVIN Edward HEALY
-
依托单位:
海外基金